About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1

Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy

A Phase I, Open-Label, Dose-Escalation Study to Investigate the Safety of ISTH0036, a 'Next Generation' TGF-β2-Selective Antisense Oligonucleotide, in Subjects With Primary Open-Angle Glaucoma Undergoing Trabeculectomy

NCT02406833•Isarna Therapeutics GmbH

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Primary Open Angle Glaucoma

Interventions

TGF-β2 antisense oligonucleotide

Trabeculectomy

Locations

3

Germany

Locations (3)

University Hospital Magdeburg, Ophthalmology

Magdeburg, Germany

Department of Ophthalmology, Johannes-Gutenberg University Mainz

Mainz, Germany

University of Tuebingen, Center of Ophthalmology

Tübingen, Germany

Key Dates

Start Date

April 1, 2015

Primary Completion Date

August 1, 2016

Completion Date

August 1, 2017

Last Updated

February 28, 2018

Related Studies

DSLT for Reducing Medication in Glaucoma

NCT07390890

Primary Open Angle GlaucomaOcular Hypertension

Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients With Primary Open-Angle Glaucoma

NCT07358650

Primary Open Angle Glaucoma

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population

NCT05902871

Primary Open Angle GlaucomaOcular Hypertension+1 more

A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients

NCT07076303

Primary Open Angle GlaucomaGlaucoma+1 more

RECRUITINGPhase 4

Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT

NCT06865144

Primary Open Angle Glaucoma or Ocular Hypertension

Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma

NCT05564091

Primary Open Angle Glaucoma

View all related studies

Sponsors

Lead Sponsor

Isarna Therapeutics GmbH

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 28, 2018Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions